Metastatic Extrahepatic Bile Duct Cancer
4 clinical trials · Condition
◉ Watch Metastatic Extrahepatic Bile Duct Cancer
| Record | Firm | Date |
|---|---|---|
| PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer (NCT02088775) | Fox Chase Cancer Center | 2014-02-01 |
| CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01766219) | Wake Forest University Health Sciences | 2013-05-01 |
| Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01859182) | National Cancer Institute (NCI) | 2013-01-01 |
Track Metastatic Extrahepatic Bile Duct Cancer automatically
Every clearance here is in the API, with alerts when new ones post.